XTX Topco’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$646K Buy
283,518
+221,400
+356% +$702K 0.01% 1788
2025
Q4
$248K Sell
62,118
-35,838
-37% -$199K 0.01% 2233
2025
Q3
$829K Buy
97,956
+21,051
+27% +$204K 0.04% 694
2025
Q2
$866K Buy
76,905
+33,697
+78% +$309K 0.04% 750
2025
Q1
$409K Buy
43,208
+19,887
+85% +$201K 0.02% 1172
2024
Q4
$262K Buy
23,321
+9,731
+72% +$171K 0.02% 1328
2024
Q3
$384K Sell
13,590
-29,791
-69% -$768K 0.03% 1019
2024
Q2
$829K Buy
43,381
+23,917
+123% +$611K 0.07% 434
2024
Q1
$638K Buy
+19,464
New +$621K 0.09% 345

Other funds holding EVH

XTX Topco's EVH Position: Q1 2026 in Review

XTX Topco increased its Evolent Health (EVH) stake by 356% in Q1 2026, buying an estimated $702K and bringing the position to 283,518 shares worth $646K. The position accounts for 0.01% of the portfolio, ranked #1788.

XTX Topco first reported a position in EVH in Q1 2024 and has held it in 9 quarters since. The position peaked at $866K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • XTX Topco held 283,518 shares of Evolent Health worth $646K as of Q1 2026.
  • XTX Topco bought 221,400 Evolent Health shares in Q1 2026, an estimated $702K.
  • Evolent Health made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1788 holding.
  • XTX Topco first reported a position in Evolent Health in Q1 2024 and has held it in 9 quarters since.
  • XTX Topco's Evolent Health position peaked at $866K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.